These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23 related articles for article (PubMed ID: 8789702)
1. Intracellular ROS production and apoptotic effect of quinoline and isoquinoline alkaloids on the growth of Trypanosoma evansi. Rani R; Sethi K; Gupta S; Virmani N; Kumar S; Kumar R Acta Trop; 2023 Sep; 245():106980. PubMed ID: 37419379 [TBL] [Abstract][Full Text] [Related]
2. Preliminary efficacy trial of Cymelarsan, a novel trypanocide, in camels naturally infected with Trypanosoma evansi in Kenya. Otsyula M; Kamar K; Mutugi M; Njogu AR Acta Trop; 1992 Feb; 50(3):271-3. PubMed ID: 1348603 [No Abstract] [Full Text] [Related]
3. Parasitological, Serological and Molecular Prevalence of Trypanosoma evansi among Arabian Camels (Camelus dromedaries) with Evaluation of Antitrypanosomal Drugs. Abdel-Rady A; Alhassan A; Mostafa W; Elhaig MM Acta Parasitol; 2024 Mar; 69(1):465-470. PubMed ID: 38190015 [TBL] [Abstract][Full Text] [Related]
4. Trypanosoma evansi infection in mainland Spain. Tamarit A; Gutierrez C; Arroyo R; Jimenez V; Zagalá G; Bosch I; Sirvent J; Alberola J; Alonso I; Caballero C Vet Parasitol; 2010 Jan; 167(1):74-6. PubMed ID: 19864069 [TBL] [Abstract][Full Text] [Related]
5. Effect of stage of infection with Trypanosoma evansi on Cymelarsan therapy. Biswas RK; Hunter AG Trop Anim Health Prod; 1993 Nov; 25(4):223-4. PubMed ID: 8109055 [No Abstract] [Full Text] [Related]
6. A comparison of the antigen detection ELISA and parasite detection for diagnosis of Trypanosoma evansi infections in camels. Waitumbi JN; Nantulya VM Vet Parasitol; 1993 Sep; 49(2-4):159-78. PubMed ID: 8249241 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy of melarsenoxyde cysteamine (Cymelarsan) in treatment of camels experimentally infected with Trypanosoma evansi using antigen trapping enzyme-linked immunosorbent assay. Nyang'ao JM; Olaho-Mukani W; Maribei JM; Omuse JK J Vet Pharmacol Ther; 1995 Dec; 18(6):468-70. PubMed ID: 8789702 [No Abstract] [Full Text] [Related]
8. Arginine kinase: a potential pharmacological target in trypanosomiasis. Pereira CA Infect Disord Drug Targets; 2014; 14(1):30-6. PubMed ID: 25019239 [TBL] [Abstract][Full Text] [Related]
9. [Compounds for treatment of trypanosoma infections]. Clement B Pharm Unserer Zeit; 1989 Jul; 18(4):97-111. PubMed ID: 2672033 [No Abstract] [Full Text] [Related]